Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of beclometasone + formoterol inhalation aerosol in asthma
CTR20243955Phase 3Active
- Sponsor
- Shandong Jianwei Pharmaceutical
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclomethasone, formoterol in asthma, sponsored by Shandong Jianwei Pharmaceutical. Started Jun 2025; status: active.
02
Drugs
beclomethasoneformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20243955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243955.